1. Medtech Insight
  2. >>Policy & Regulation

Carrot’s Pivot Breath Sensor Helps Motivate Smokers To Quit

 
• By Reed Miller

Based on the results of a study with 234 smokers, the FDA cleared an updated indication for Carrot’s Pivot breath sensor, an over-the-counter carbon monoxide sensor that helps motivate people to stop smoking.

Carrot Pivot Sensor User
• Source: Carrot, Inc.

Carrot Inc. is marketing its Pivot carbon monoxide breath sensor as the only over-the-counter device proven to increase smokers’ motivation to quit smoking.

The US Food and Drug Administration cleared Carrot’s expanded labeling claim for the device via a 510(k) based on a clinical trial, the Silicon Valley digital health company announced...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

FDLI: Clinical Labs Face Uncertainty After Texas Court’s LDT Ruling

 
• By Elizabeth Orr

A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.